The ubiquitin system and Kaposi's sarcoma-associated herpesvirus

Frontiers in Microbiology

Volumn 3, Issue FEB, 2012, Pages

  Ashizawa, Akira ^a   Higashi, Chizuka ^a   Masuda, Kazuki ^a   Ohga, Rie ^a   Taira, Takahiro ^a   Fujimuro, Masahiro ^b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Kaposi's sarcoma associated herpesvirus; Polyubiquitin; Proteasome; RING; Ubiquitin

Indexed keywords

EID: 84875630486     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00066     Document Type: Article

References (79)

1. Abada, R., Dreyfuss-Grossman, T., Herman-Bachinsky, Y., Geva, H., Masa, S. R., and Sarid, R. (2008). SIAH-1 interacts with the Kaposi's sarcoma-associated herpesvirus-encoded ORF45 protein and promotes its ubiquitylation and proteasomal degradation. J. Virol. 82,2230-2240.
2. Ahmad, H., Gubbels, R., Ehlers, E., Meyer, F., Waterbury, T., Lin, R., and Zhang, L. (2011). Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF). J. Biol. Chem. 286, 7865-7872.
3. Ballestas, M. E., Chatis, P. A., and Kaye, K. M. (1999). Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641-644.
4. Bieniasz, P. D. (2006). Late budding domains and host proteins in enveloped virus release. Virology 344, 55-63.
5. Bosanac, I., Phu, L., Pan, B., Zilber-leyb, I., Maurer, B., Dixit, V. M., Hymowitz, S. G., and Kirkpatrick, D. S. (2011). Modulation of K11-linkage formation by variable loop residues within UbcH5A. J. Mol. Biol. 408,420-431.
6. Brander, C., Suscovich, T., Lee, Y., Nguyen, P. T., O'Connor, P., See-bach, J., Jones, N. G., van Gorder, M., Walker, B. D., and Scadden, D. T. (2000). Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus. J. Immunol. 165, 2077-2083.
7. Bubman, D., Guasparri, I., and Cesar-man, E. (2007). Deregulation of c-Myc in primary effusion lym-phoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen. Oncogene 26,4979-4986.
8. Cai, Q. L., Knight, J. S., Verma, S. C., Zald, P., and Robertson, E. S. (2006). EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog. 2, e116. doi:10.1371/jour-nal.ppat.0020116
9. Canning, M., Boutell, C., Parkinson, J., and Everett, R. D. (2004). A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7. J. Biol Chem. 279, 38160-38168.
10. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., and Moore, P. S. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associatedKaposis sarcoma. Science 266,1865-1869.
11. Chang, Y., Moore, P. S., Talbot, S. J., Boshoff, C. H., Zarkowska, T., Godden-Kent, Paterson, H., Weiss, R. A., and Mittnacht, S. (1996). Cyclin encoded by KS herpesvirus. Nature 382, 410.
12. Chaudhary, P. M., Jasmin, A., Eby, M. T., and Hood, L. (1999). Modulation of the NF-(Κ B pathway by virally encoded death effector domains-containing proteins. Oncogene 18, 5738-5746.
13. Chugh, P., Matta, H., Schamus, S., Zachariah, S., Kumar, A., Richardson, J. A., Smith, A. L., and Chaudhary, P. M. (2005). Constitutive NF-ΚB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc. Natl Acad. Sci. U.S.A. 102, 12885-12890.
14. Ciechanover, A. (2005). Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat. Rev. Mol Cell Biol. 6, 79-87.
15. Coscoy, L., and Ganem, D. (2000). Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. U.S.A. 97, 8051-8056.
16. Coscoy, L., and Ganem, D. (2001). A viral protein that selectively down-regulates ICAM-1 and B7-2 and modulates T cell costimulation. J. Clin. Invest. 107,1599-1606.
17. Coscoy, L., Sanchez, D. J., and Ganem, D. (2001). A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J. Cell Biol. 155, 1265-1273.
18. Deng, H., Liang, Y., and Sun, R. (2007). Regulation of KSHV lytic gene expression, Curr. Top. Micro-biol. Immunol. 312, 157-183.
19. Diehl, J. A., Cheng, M., Roussel, M. F., and ana Sherr, C. J. (1998). Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511.
20. Duncan, L. M., Piper, S., Dodd, R. B., Saville, M. K., Sanderson, C. M., Luzio, J. P., and Lehner, P. J. (2006). Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J. 25,1635-1645.
21. Ellis, M., Chew, Y. P., Fallis, L., Fredders-dorf, S., Boshoff, C., Weiss, R. A., Lu, X., and Mittnacht, S. (1999). Degradation of p27 (Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J. 18, 644-653.
22. Feng, H., Dong, X., Negaard, A., and Feng, P. (2008). Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumori-genicity. PLoS Pathog. 4, e1000157. doi:10.1371/journal.ppat.1000157
23. Feng, P., Scott, C. W., Cho, N. H., Nakamura, H., Chung, Y. H., Monteiro, M. J., and Jung, J. U. (2004). Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation. Mol. Cell. Biol. 24, 3938-3948.
24. Field, N., Low, W., Daniels, M., How-ell, S., Daviet, L., Boshoff, C., and Collins, M. (2003). KSHV vFLIP binds to IKK-gamma to activate IKK.J. CellSci. 116,3721-3728.
25. Friborg, J. J., Kong, W., Hottiger, M. O., and Nabel, G. J. (1999). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402,889-894.
26. Fujimuro, M., and Hayward, S. D. (2003). The latency-associated nuclear antigen of Kaposis sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J. Virol. 77, 8019-8030
27. Fujimuro, M., Liu, J., Zhu, J., Yokosawa, H., and Hayward, S. D. (2005). Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. J. Virol. 79,10429-10441.
28. Fujimuro, M., Wu, F. Y., Aprhys, C., Kajumbula, H., Young, D. B., Hayward, G. S., and Hayward, S. D. (2003). A novel viral mechanism for dysregulation of beta-catenin in Kaposis sarcoma-associated herpesvirus latency. Nat. Med. 9, 300-306.
29. Ganem, D. (2007). 'Kaposi's sarcoma-associated herpesvirus,' in Fields' Virology, 5th Edn, eds D. M. Knipe and P. M. Howley (Philadelphia, PA: Lippincott Williams and Wilkins), 2847-2888.
30. González, C. M., Wang, L., and Dama-nia, B. (2009). Kaposi's sarcoma-associated herpesvirus encodes a viral deubiquitinase. J. Virol. 83, 10224-11033.
31. Gould, F., Harrison, S. M., Hewitt, E. W., and Whitehouse, A. (2009). Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway. J. Virol. 83, 6727-6738.
32. Guasparri, I., Wu, H., and Cesarman, E. (2006). The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling, EMBO Rep. 7, 114-119.
33. Hayward, S. D., Liu, J., and Fujimuro, M. (2006). Notch and Wnt Signaling: Mimicry and manipulation by γ herpesviruses. Sci. STKE 335, re4.
34. Hicke, L. (1999). Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol. 9, 107-112.
35. Hicke, L. (2001). Protein regulation by monoubiquitin. Nat. Rev. Mol Cell Biol. 2,195-201.
36. Holowaty, M. N., and Frappier, L. (2004). HAUSP/USP7 as an Epstein-Barr virus target. Biochem. Soc. Trans. 32,731-732.
37. Inn, K. S., Lee, S. H., Rathbun, J. Y., Wong, L. Y., Toth, Z., Machida, K., Ou, J. H., and Jung, J. U. (2011). Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J. Virol. 85, 10899-10904.
38. Ishido, S., Wang, C., Lee, B. S., Cohen, G. B., and Jung, J. U. (2000a). Down-regulation of major histocompat-ibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74, 5300-5309.
39. Ishido, S., Choi, J. K., Lee, B. S., Wang, C., DeMaria, M., Johnson, R. P., Cohen, G. B., and Jung, J. U. (2000b). Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13, 365-374.
40. Jang, K. L., Shackelford, J., Seo, S. Y., and Pagano, J. S. (2005). Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Proc. Natl. Acad. Sci. U.S.A. 102, 18431-18436.
41. Järviluoma, A., Child, E. S., Sarek, G., Sirimongkolkasem, P., Peters, G., Ojala, P. M., and Mann, D. J. (2006). Phosphorylation of the cyclin-dependent kinase inhibitor p21Cip1 on serine 130 is essential for viral cyclin-mediated bypass of a p21Cip1-imposed G1 arrest. Mol. Cell. Biol. 26, 2430-2440.
42. Järviluoma, A., Koopal, S., Rasanen, S., Makela, T. P., and Ojala, P. M. (2004). KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas. Blood 104, 3349-3354.
43. Järviluoma, A., and Ojala, P. M. (2006). Cell signaling pathways engaged by KSHV. Biochim. Biophys. Acta 1766, 140-158.
44. Jenner, R. G., and Boshoff, C. (2002). The molecular pathology of Kaposis sarcoma-associated herpesvirus. Biochim. Biophys. Acta 1602, 1-22.
45. Keller, S. A., Schattner, E. J., and Cesarman, E. (2000). Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96, 2537-2542.
46. Kwun, H. J., da Silva, S. R., Qin, H., Ferris, R. L., Tan, R., Chang, Y., and Moore, P. S. (2011). The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation. Virology 412, 357-365.
47. Kwun, H. J., da Silva, S. R., Shah, I. M., Blake, N., Moore, P. S., and Chang, Y. (2007). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.J. Virol. 81, 8225-8235.
48. Lan, K., Verma, S. C., Murakami, M., Bajaj, B., Kaul, R., and Robertson, E. S. (2007). Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc. Natl. Acad. Sci. U.S.A. 104, 16287-16292.
49. Lee, H. R., Toth, Z., Shin, Y. C., Lee, J. S., Chang, H., Gu, W., Oh, T. K., Kim, M. H., and Jung, J. U. (2009). Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway. J. Virol. 83, 6739-6747.
50. Lei, X., Bai, Z., Ye, F., Xie, J., Kim, C. G., Huang, Y., and Gao, S. J. (2010). Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat. Cell Biol. 12, 193-199.
51. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., and Masucci, M. G. (1995). Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375, 685-688.
52. Li, Q., Means, R., Lang, S., and Jung, J. U. (2007). Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 andK5.J. Virol. 81,2117-2127.
53. Liang, Y., and Ganem, D. (2003). Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl. Acad. Sci. U.S.A. 100, 8490-8495.
54. Lipkowitz, S., and Weissman, A. M. (2011). RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer 11,629-643.
55. Liu, J., Martin, H., Shamay, M., Woodard, C., Tang, Q. Q., and Hayward, S. D. (2007). Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation. J. Virol. 81, 4722-4731.
56. Liu, L., Eby, M. T., Rathore, N., Sinha, S. K., Kumar, A., and Chaudhary, P. M. (2002). The human herpesvirus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the ikappa B kinase complex. J. Biol. Chem. 277, 13745-13751.
57. Mann, D. J., Child, E. S., Swan-ton, C., Laman, H., and Jones, N. (1999). Modulation of p27 (Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBOJ. 18, 654-663.
58. Mansouri, M., Douglas, J., Rose, P. P., Gouveia, K., Thomas, G., Means, R. E., Moses, A. V., and Früh, K. (2006). Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Blood 108, 1932-1940.
59. Mansouri, M., Viswanathan, K., Douglas, J. L., Hines, J., Gustin, J., Moses, A.V., and Früh, K. (2009). Molecular mechanism of BST2/tetherin down-regulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 83, 9672-9681.
60. Matsumoto, A., Onoyama, I., Suna-bori, T., Kageyama, R., Okano, H., and Nakayama, K. I. (2011). Fbxw7-dependent degradation of Notch is required for control of 'stemness' and neuronal-glial differentiation in neural stem cells. J. Biol. Chem. 286, 13754-13764.
61. Mittnacht, S., and Boshoff, C. (2000). Viral cyclins. Rev. Med. Virol. 10, 175-184.
62. Nakayama, K. I., and Nakayama, K. (2006). Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6,369-381.
63. Pardieu, C., Vigan, R., Wilson, S. J., Calvi, A., Zang, T., Bieniasz, P., Kellam, P., Towers, G. J., and Neil, S. J. (2010). The RING-CH lig-ase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of teth-erin. PLoS Pathog. 6, e1000843. doi:10.1371/journal.ppat.1000843
64. Pickart, C. M. (2001). Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533.
65. Radkov, S. A., Kellam, P., and Boshoff, C. (2000). The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene H-ras transforms primary rat cells. Nat. Med. 6,1121-1127.
66. Rhodes, D. A., Boyle, L. H., Boname, J. M., Lehner, P. J., and Trows-dale, J. (2010). Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradation. Proc. Natl. Acad. Sci. U.S.A. 107, 16240-16245.
67. Russo, J. J., Bohenzky, R. A., Chein, M. C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edel-man, I. S., Chang, Y., and Moore, P. S. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A. 93, 14862-14867.
68. Sanchez, D. J., Gumperz, J. E., and Ganem, D. (2005). Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Invest. 115,1369-1378.
69. Shin, Y C, Nakamura, H., Liang, X., Feng, P., Chang, H., Kowalik, T. F., and Jung, J. U. (2006). Inhibition of the ATM/p53 signal transduc-tion pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J. Virol. 80, 2257-2266.
70. Sulea, T., Lindner, H. A., and Menard, R. (2006). Structural aspects of recently discovered viral deubiqui-tinating activities. Biol. Chem. 387, 853-862.
71. Swanton, C., Mann, D. J., Flecken-stein, B., Neipel, F., Peters, G., and Jones, N. (1997). Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390,184-187.
72. Thomas, M., Boname, J. M., Field, S., Nejentsev, S., Salio, M., Cerun-dolo, V., Wills, M., and Lehner, P. J. (2008). Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxic-ity. Proc. Natl. Acad. Sci. U.S.A. 105, 1656-1661.
73. Weissman, A. M., Shabek, N., and Ciechanover, A. (2011). The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat. Rev. Mol. Cell Biol. 12, 605-620.
74. Yada, M., Hatakeyama, S., Kamura, T., Nishiyama, M., Tsunematsu, R., Imaki, H., Ishida, N., Okumura, F., Nakayama, K., and Nakayama, K. I. (2004).Phosphorylation-dependent degradation of c-Myc is mediated by theF-boxproteinFbw7. EMBOJ. 23, 2116-2125.
75. Yang, Z., Yan, Z., and Wood, C. (2008). Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication. J. Virol. 82, 3590-35603.
76. Yin, Y., Manoury, B., and Fahraeus, R. (2003). Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301, 1371-1374.
77. Yu, Y., and Hayward, G. S. (2010). The ubiquitin E3 ligase RAUL negatively regulates type-I interferon through ubiquitination of IRF7 and IRF3. Immunity 33, 863-877.
78. Yu, Y., Wang, S. E., and Hayward, G. S. (2005). The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22, 59-70.
79. Zaldumbide, A., Ossevoort, M., Wiertz, E. J., and Hoeben, R. C. (2007). In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcomaherpes virus. Mol. Immunol. 44,1352-1360.